Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01595308 · ClinicalTrials.gov registry record · Phase 1

A Pilot Study to Evaluate the Effect of Pomegranate Juice on Semen Parameters in Healthy Male Volunteers

A Phase 1 study of Male Infertility, sponsored by POM Wonderful.

Completed
Registry status
Phase 1
Development phase
12
Enrollment target
1
Study location

NCT01595308: Completed Phase 1 study of Male Infertility, sponsored by POM Wonderful.

NCT01595308 is a Phase 1 study of Male Infertility that has completed, run by POM Wonderful. The registered enrollment target is 12 participants, below the 557-participant average among 8 other Male Infertility trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01595308, a Phase 1 study of Male Infertility, has completed, sponsored by POM Wonderful.

COMPLETED
Registry status
Phase 1
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

How daily consumption of pomegranate juice affects the concentration, morphology or motility of sperm in healthy men.

Primary Outcome

The primary outcome will be change in sperm counts relative to baseline with and without POM.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Pomegranate juice

Study Locations (1)

California

  • Clinical Trials Program at University of California - Los Angeles

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2011-04
Est. Completion 2012-05
Phase Phase 1
POM Wonderful

5 total trials

What the finished NCT01595308 record still lists

NCT01595308 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 557-participant average among 8 other Male Infertility trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Male Infertility appearing as the primary indexed condition, and to 1 intervention - of which Pomegranate juice is the first listed.

NCT01595308 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01595308 about?

NCT01595308 is a clinical study titled "A Pilot Study to Evaluate the Effect of Pomegranate Juice on Semen Parameters in Healthy Male Volunteers". How daily consumption of pomegranate juice affects the concentration, morphology or motility of sperm in healthy men.

What is the current status of trial NCT01595308?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2011-04. Estimated completion is 2012-05.

What conditions does trial NCT01595308 study?

This clinical trial studies the following conditions: Male Infertility.

What interventions are being tested in trial NCT01595308?

The interventions under investigation include: Pomegranate juice (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01595308?

This trial is sponsored by POM Wonderful, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01595308 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Male Infertility

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01595308's enrollment target sits among peer trials

12 8th of 8 higher than 1 of 8 other Male Infertility trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Male Infertility trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01595308, the US trial registry maintained by the National Library of Medicine. NCT01595308 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.